Bio-Rad Laboratories EPS - Earnings per Share 2010-2023 | BIO
- Bio-Rad Laboratories EPS for the quarter ending December 31, 2023 was $11.81, a 56.64% decline year-over-year.
- Bio-Rad Laboratories EPS for the twelve months ending December 31, 2023 was $-21.82, a 82.08% decline year-over-year.
- Bio-Rad Laboratories 2023 annual EPS was $-21.82, a 82.08% decline from 2022.
- Bio-Rad Laboratories 2022 annual EPS was $-121.79, a 186.48% decline from 2021.
- Bio-Rad Laboratories 2021 annual EPS was $140.83, a 11.35% increase from 2020.
Bio-Rad Laboratories Annual EPS | |
---|---|
2023 | $-21.82 |
2022 | $-121.79 |
2021 | $140.83 |
2020 | $126.47 |
2019 | $58.27 |
2018 | $12.10 |
2017 | $4.07 |
2016 | $0.88 |
2015 | $3.71 |
2014 | $3.05 |
2013 | $2.69 |
2012 | $5.78 |
2011 | $6.29 |
2010 | $6.59 |
2009 | $5.20 |
Bio-Rad Laboratories Quarterly EPS | |
---|---|
2023-12-31 | $11.81 |
2023-09-30 | $3.64 |
2023-06-30 | $-39.59 |
2023-03-31 | $2.32 |
2022-12-31 | $27.24 |
2022-09-30 | $-5.48 |
2022-06-30 | $-31.05 |
2022-03-31 | $-112.50 |
2021-12-31 | $-51.83 |
2021-09-30 | $129.96 |
2021-06-30 | $30.32 |
2021-03-31 | $32.38 |
2020-12-31 | $27.96 |
2020-09-30 | $43.64 |
2020-06-30 | $32.15 |
2020-03-31 | $22.72 |
2019-12-31 | $18.35 |
2019-09-30 | $-8.68 |
2019-06-30 | $19.86 |
2019-03-31 | $28.74 |
2018-12-31 | $-27.43 |
2018-09-30 | $8.89 |
2018-06-30 | $8.87 |
2018-03-31 | $21.77 |
2017-12-31 | $2.76 |
2017-09-30 | $0.73 |
2017-06-30 | $0.17 |
2017-03-31 | $0.41 |
2016-12-31 | $-0.77 |
2016-09-30 | $0.62 |
2016-06-30 | $0.61 |
2016-03-31 | $0.42 |
2015-12-31 | $1.54 |
2015-09-30 | $0.59 |
2015-06-30 | $0.97 |
2015-03-31 | $0.61 |
2014-12-31 | $1.34 |
2014-09-30 | $0.39 |
2014-06-30 | $1.09 |
2014-03-31 | $0.23 |
2013-12-31 | $1.04 |
2013-09-30 | $-0.25 |
2013-06-30 | $1.20 |
2013-03-31 | $0.70 |
2012-12-31 | $1.51 |
2012-09-30 | $1.49 |
2012-06-30 | $1.69 |
2012-03-31 | $1.09 |
2011-12-31 | $2.11 |
2011-09-30 | $1.61 |
2011-06-30 | $1.41 |
2011-03-31 | $1.16 |
2010-12-31 | $2.41 |
2010-09-30 | $1.59 |
2010-06-30 | $1.35 |
2010-03-31 | $1.24 |
2009-12-31 | $1.35 |
2009-09-30 | $1.38 |
2009-06-30 | $1.37 |
2009-03-31 | $1.10 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $8.014B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.663B | 23.98 |
Stryker (SYK) | United States | $124.585B | 30.89 |
Medtronic (MDT) | Ireland | $105.150B | 14.89 |
Boston Scientific (BSX) | United States | $98.912B | 32.89 |
EssilorLuxottica (ESLOY) | France | $98.803B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.442B | 0.00 |
Haleon (HLN) | United Kingdom | $37.123B | 29.04 |
ResMed (RMD) | United States | $26.124B | 26.12 |
Terumo (TRUMY) | Japan | $24.607B | 34.75 |
Zimmer Biomet Holdings (ZBH) | United States | $24.518B | 15.78 |
Baxter (BAX) | United States | $20.135B | 14.69 |
Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
Insulet (PODD) | United States | $11.535B | 60.56 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.496B | 0.00 |
Demant (WILYY) | Denmark | $9.782B | 0.00 |
BellRing Brands (BRBR) | United States | $7.103B | 38.19 |
Lantheus Holdings (LNTH) | United States | $4.273B | 11.03 |
Haemonetics (HAE) | United States | $4.239B | 21.68 |
Perrigo (PRGO) | Ireland | $4.057B | 11.60 |
GN Store Nord (GNNDY) | Denmark | $3.581B | 23.19 |
Envista Holdings (NVST) | United States | $3.394B | 12.91 |
Prestige Consumer Healthcare (PBH) | United States | $3.394B | 16.05 |
Green Thumb Industries (GTBIF) | United States | $2.720B | 86.20 |
Neogen (NEOG) | United States | $2.584B | 24.85 |
QuidelOrtho (QDEL) | United States | $2.559B | 9.29 |
ICU Medical (ICUI) | United States | $2.361B | 17.62 |
TG Therapeutics (TGTX) | United States | $2.160B | 699.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.913B | 0.00 |
Owens & Minor (OMI) | United States | $1.843B | 17.69 |
Verano Holdings (VRNOF) | United States | $1.841B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.654B | 0.00 |
National Vision Holdings (EYE) | United States | $1.466B | 45.66 |
InMode (INMD) | Israel | $1.456B | 7.54 |
LeMaitre Vascular (LMAT) | United States | $1.406B | 46.38 |
AdaptHealth (AHCO) | United States | $1.244B | 9.36 |
Warby Parker (WRBY) | United States | $1.169B | 0.00 |
AtriCure (ATRC) | United States | $1.131B | 0.00 |
MacroGenics (MGNX) | United States | $1.005B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
Canopy Growth (CGC) | Canada | $0.713B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.687B | 14.84 |
Evolus (EOLS) | United States | $0.670B | 0.00 |
Jin Medical (ZJYL) | China | $0.617B | 0.00 |
Quanterix (QTRX) | United States | $0.604B | 0.00 |
Valneva SE (VALN) | France | $0.565B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.528B | 11.44 |
TerrAscend (TSNDF) | Canada | $0.507B | 0.00 |
PetIQ (PETQ) | United States | $0.472B | 17.61 |
ZimVie (ZIMV) | United States | $0.427B | 26.13 |
Biote (BTMD) | United States | $0.405B | 3.86 |
OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
Surmodics (SRDX) | United States | $0.376B | 40.60 |
Zynex (ZYXI) | United States | $0.368B | 42.41 |
Aurora Cannabis (ACB) | Canada | $0.356B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.302B | 30.00 |
Cerus (CERS) | United States | $0.297B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.241B | 14.71 |
Veru (VERU) | United States | $0.208B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.193B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Omeros (OMER) | United States | $0.186B | 0.00 |
High Tide (HITI) | Canada | $0.175B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.148B | 0.00 |
FitLife Brands (FTLF) | United States | $0.134B | 21.55 |
Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
InterCure (INCR) | Israel | $0.118B | 19.92 |
Fonar (FONR) | United States | $0.106B | 9.14 |
MariMed (MRMD) | United States | $0.104B | 0.00 |
Safety Shot (SHOT) | United States | $0.099B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.098B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.083B | 0.00 |
Brainsway (BWAY) | Israel | $0.080B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
Apyx Medical (APYX) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 14.04 |
Exagen (XGN) | United States | $0.025B | 0.00 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
GlucoTrack (GCTK) | United States | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 73.18 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |